Yuan Chenchen
About Yuan Chenchen
Yuan Chenchen is a Beam Physics Engineer with extensive experience in proton therapy systems. He has worked at IBA since 2015, following roles at SGS and United Imaging Healthcare, and holds a Bachelor's degree in Nuclear Engineering Technology from East China Institute of Technology.
Work at IBA
Yuan Chenchen has been employed at IBA since 2015, serving as a Beam Physics Engineer. In this role, he focuses on proton therapy, contributing to the development and optimization of beam delivery systems. His responsibilities include ensuring the accuracy and efficiency of proton therapy systems, which are critical for effective cancer treatment. With over nine years of experience at IBA, he plays a vital role in advancing the technology used in proton therapy.
Previous Experience in Radiation Therapy
Before joining IBA, Yuan Chenchen worked at United Imaging Healthcare as an R&D System Engineer from 2013 to 2015. His work focused on radiation therapy, where he contributed to the research and development of systems used in this field. Prior to that, he served as a Technical Support Engineer at SGS from 2011 to 2013, where he worked in a chemistry laboratory, providing technical support and expertise.
Education and Expertise
Yuan Chenchen earned a Bachelor's degree in Nuclear Engineering Technology/Technician from East China Institute of Technology, where he studied from 2006 to 2010. His educational background provides a strong foundation for his expertise in beam physics and proton therapy. He is skilled in calibrating and validating beam delivery systems, as well as troubleshooting and maintaining cyclotron and energy selection systems.
Technical Skills in Proton Therapy
Yuan Chenchen possesses specialized skills in the clinical application of patient positioning verification systems, utilizing CBCT and X-ray technologies. He is experienced in CFDA verification processes for proton therapy systems, ensuring compliance with regulatory standards. His technical skills support the safe and effective delivery of proton therapy treatments.